Barclays PLC Purchases 6,899 Shares of CBIZ, Inc. (NYSE:CBZ)

Barclays PLC grew its stake in CBIZ, Inc. (NYSE:CBZ - Free Report) by 8.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 85,610 shares of the business services provider's stock after acquiring an additional 6,899 shares during the quarter. Barclays PLC owned 0.17% of CBIZ worth $7,005,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of CBZ. Smartleaf Asset Management LLC increased its stake in shares of CBIZ by 75.0% in the 4th quarter. Smartleaf Asset Management LLC now owns 644 shares of the business services provider's stock valued at $53,000 after acquiring an additional 276 shares during the last quarter. VisionPoint Advisory Group LLC bought a new stake in shares of CBIZ in the 4th quarter valued at about $60,000. Venturi Wealth Management LLC bought a new stake in shares of CBIZ in the 4th quarter valued at about $110,000. KBC Group NV increased its stake in shares of CBIZ by 30.1% in the 4th quarter. KBC Group NV now owns 2,021 shares of the business services provider's stock valued at $165,000 after acquiring an additional 468 shares during the last quarter. Finally, Nisa Investment Advisors LLC increased its stake in shares of CBIZ by 31.2% in the 4th quarter. Nisa Investment Advisors LLC now owns 2,227 shares of the business services provider's stock valued at $182,000 after acquiring an additional 529 shares during the last quarter. 87.44% of the stock is owned by institutional investors.

CBIZ Stock Up 1.3 %

Shares of NYSE CBZ traded up $0.85 during trading hours on Wednesday, hitting $68.07. The company had a trading volume of 472,582 shares, compared to its average volume of 340,194. The firm's 50 day moving average is $74.10 and its 200-day moving average is $77.91. CBIZ, Inc. has a 1-year low of $62.66 and a 1-year high of $90.13. The stock has a market capitalization of $3.68 billion, a P/E ratio of 28.84 and a beta of 0.90. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 0.36.

CBIZ (NYSE:CBZ - Get Free Report) last posted its earnings results on Thursday, April 24th. The business services provider reported $2.29 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.11 by $0.18. The company had revenue of $838.01 million during the quarter, compared to analysts' expectations of $860.25 million. CBIZ had a net margin of 7.08% and a return on equity of 15.12%. CBIZ's quarterly revenue was up 69.5% compared to the same quarter last year. During the same quarter last year, the company posted $1.54 EPS. On average, analysts expect that CBIZ, Inc. will post 2.65 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

CBZ has been the subject of several research analyst reports. William Blair reiterated an "outperform" rating on shares of CBIZ in a research report on Friday, April 25th. StockNews.com lowered CBIZ from a "hold" rating to a "sell" rating in a research report on Tuesday, February 25th.

Insider Activity at CBIZ

In related news, Director Benaree Pratt Wiley sold 6,526 shares of the company's stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $71.75, for a total value of $468,240.50. Following the transaction, the director now owns 41,759 shares in the company, valued at approximately $2,996,208.25. This represents a 13.52 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 4.95% of the stock is owned by company insiders.

About CBIZ

CBIZ, Inc provides financial, insurance, and advisory services in the United States and Canada. It operates through Financial Services, Benefits and Insurance Services, and National Practices segments. The Financial Services segment offers accounting and tax, financial advisory, valuation, risk and advisory, and government healthcare consulting services.